Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions (NCT07654283)
A Phase 2 Multi-center, Randomized, Open-label Study to Assess the Efficacy and Safety of AHB-137 in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B in the North America and Europe Regions
🩺 Plain-English Summary (8th-Grade Level)
This study is a randomized, open-label, multicenter phase 2 clinical trial to evaluate the efficacy and safety of AHB-137 injection in participants with CHB treated with Nucleos(t)ide Analogue (NAs).
Who can join: Review the eligibility criteria below.
Location: Stanford University — Palo Alto, California
Age range: 18 Years to 65 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (10 Sites)
- Stanford University — Palo Alto, California
- University of Maryland — Baltimore, Maryland
- NYU Langone Health — New York, New York
- Texas Liver Institute — San Antonio, Texas
- University of Calgary — Calgary, Alberta
- Toronto General Hospital — Toronto, Ontario
- Hôpital Beaujon — Clichy,
- Clinica Mangiagalli — Milan, Milan
- Vall d'Hebron Hospital — Barcelona, Barcelona
- King's College Hospital — London, London
📞 Contact the Study Coordinator
Phone: (650) 650-2877
Email: ausperbioclinicaltrials@ausperbio.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Hepatitis B, Chronic
Explore by condition: All Hepatitis B, Chronic clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.